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Small ruminant lentiviruses (SRLV) infect the monocyte/macrophage lineage inducing a long-lasting infection
affecting body condition, production and welfare of sheep and goats all over the world. Macrophages play a
pivotal role on the host’s innate and adaptative immune responses against parasites by becoming differentially
activated. Macrophage heterogeneity can tentatively be classified into classically differentiated macrophages (M1)
through stimulation with IFN-γ displaying an inflammatory profile, or can be alternatively differentiated by
stimulation with IL-4/IL-13 into M2 macrophages with homeostatic functions. Since infection by SRLV can modulate
macrophage functions we explored here whether ovine and caprine macrophages can be segregated into M1 and
M2 populations and whether this differential polarization represents differential susceptibility to SRLV infection. We
found that like in human and mouse systems, ovine and caprine macrophages can be differentiated with particular
stimuli into M1/M2 subpopulations displaying specific markers. In addition, small ruminant macrophages are plastic
since M1 differentiated macrophages can express M2 markers when the stimulus changes from IFN-γ to IL-4. SRLV
replication was restricted in M1 macrophages and increased in M2 differentiated macrophages respectively
according to viral production. Identification of the infection pathways in macrophage populations may provide new
targets for eliciting appropriate immune responses against SRLV infection.Introduction
Small Ruminant Lentivirus (SRLV) infection is spreading
all over the world, with new descriptions in countries
such as Poland [1], Sultanate of Oman, Canada [2],
Slovenia [3], Russia [4] and new genotypes such as A12,
A14 and A15 [3], E and B3 [5-7]. Today, highly efficient
prophylactic/therapeutic measures against SRLV do not
exist, and control is frequently based on early diagnosis
and culling of seropositive ewes and their progeny. SRLV
infection occurs early after parturition by the lactogenic
route or direct contact with infected animals. The main
target cells for the virus in vivo are the monocyte/
macrophage lineage [8] whereas CD4 T cells and den-
dritic cells also play important roles [9,10]. Upon infec-
tion, initial viral replication triggers T cell and antibody
responses that control virus burst and allow serological
diagnosis. Following this stage, viral infection is partially* Correspondence: ramses.reina@unavarra.es
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reproduction in any medium, provided the orcontrolled but provirus is already integrated at low levels
into the cellular genome mainly of monocytes, myeloid
cells or tissue macrophages [11]. The provirus remains
latently integrated until viral proteins are produced and
new virions are released. This results in a continuous
process of low viral replication together with expression
of pro-inflammatory cytokines and chemokines that
often lead to a strong inflammatory process, tissue dam-
age and disease development [11]. The permissiveness of
macrophages to SRLV in vitro is modulated by cyto-
kines. Specifically, IFN-γ restricts SRLV replication by
delaying macrophage maturation [12-14], whereas in-
creased IL-8, GM-CSF, IL-16, IL-1beta, IL-4 and IL-10
have been associated in vivo to seropositivity [15-18]
and SRLV replication in vitro.
Cells of the monocyte-macrophage lineage are heteroge-
neous reflecting the plasticity and versatility of the re-
sponse to environmental stimuli required for effective
immune responses. Different patterns of macrophage ma-
turation have been identified in humans and mice according
to differentiation mechanisms and identification of markersLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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phenotype) and alternative activations (M2 phenotype) de-
pend on the presence of molecules secreted by T-helper
CD4 or NK cells [20]. In particular, M1 phenotype is in-
duced by Th1-signature cytokines such as IFN-γ and
TNF-α as well as LPS, resulting in enhanced microbicidal
ability in addition to increased proinflammatory responses
and cellular immunity [21]. In HIV-1 infection, the M1 pro-
file is characterized by down-regulation of CD4 receptors,
increased CCR5-binding chemokines and significantly de-
creased viral production, likely at pre-integration steps
[22]. On the contrary, the M2 phenotype is displayed
after induction with Th2-hallmark cytokines such as IL-4
and IL-13, which play a major role in responses against
parasites, allergy, wound healing, tissue remodeling or in
some cases to regulate the immune response [23].
In contrast with humans and mice, data on macrophage
polarization and its effect on lentiviral infection are lacking
in other animal species. This study aimed to investigate
whether sheep and goats, both targets to SRLV infections,
also display macrophage subpopulations. For this, we ex-
plored putative stimuli that would elicit such subpopula-
tions and determined cell markers to identify them. With
the information obtained, we investigated if the putative
subpopulations had different permissiveness and effective-
ness of infection by different strains of SRLV, according to
performance in an entry assay and retrotranscriptase acti-
vity, respectively.
Materials and methods
Cells and viruses
Fibroblastic-like cells from skin biopsies were obtained
from SRLV-free animals. Cells were grown in DMEM
medium supplemented with 10% foetal bovine serum, 2%
L-glutamine, 1% antibiotics/antimycotics mix and 1:1000
gentamicin (Sigma-Aldrich, Steinheim, Germany).
Blood monocyte-derived macrophages (MDM) were
obtained by isolation of peripheral blood mononuclear
cells (PBMC) from SRLV-free sheep and goats in com-
pliance with the relevant National legislation on experi-
mental animals and animal welfare, upon authorization
by the competent authority (Italian Ministry of Health-
Directorate General Animal Health-Office VI, permit
no.07/2009B), by Ficoll (1.077) gradient centrifugation.
MDM were grown in RPMI complete medium, containing
RPMI 1640 supplemented with 10% foetal goat serum,
10 mM sodium pyruvate, 1% non-essential amino acids,
1% vitamins, 1% antibiotics/antimycotics mix and 1:1000
gentamicin, 1% L-glutamine and 50 μM 2-mercaptoetanol
(Sigma-Aldrich).
HEK293-T cells were cultured in DMEM (GIBCO,
Invitrogen, Paisley, UK) supplemented with 10% foetal
bovine serum, 1% antibiotics/antimycotics and 1:1000
gentamicin.CHO cells and CHO-MR cells expressing mouse man-
nose receptor (kindly provided by Dr Luisa Martínez-
Pomares; [24]) were cultured in F12 nutrient mixture
with 10% foetal bovine serum, 1% L-glutamine, 1% anti-
biotics/antimycotics and 1:1000 gentamicin.
Six different SRLV strains were used, one from the geno-
type A VMV-like Ev1 strain [25], three of them belonging
to the genotype B CAEV-Co [26] and CAEV-To1/89
(B1, [27]), and 496 (B2, [28]) and two belonging to the
genotype E, Roccaverano (E1, [5] and Seui (E2, [6]).
Cytokine expression
Different small ruminant cytokines were used as well as
LPS (Sigma) as stimulators for macrophage polarization.
Plasmid pN3-IFN-γ containing the ovine IFN-γ gene
was kindly provided by Dr Marie Suzan-Monti (Faculté
de Médecine, Marseille, France).
Primer design for caprine IL-4, IL-13 and IL-10 cloning
(Table 1) was based on sequences available at Genbank
(accession numbers U34273.1, NM_001082594 and U11421,
respectively). Primers contained specific restriction sites
(XhoI and Acc651) for posterior subcloning into the
pN3 eukaryotic expression vector. pN3 is derived from
pN3-EGFP (Clontech Laboratories, Saint-Germain-en-Laye,
France) from which the EGFP gene was removed [29].
All the forward primers contained the Kozak consensus
sequence ACC. ATG.G.
Polymerase chain reactions (PCR) were performed in a
final volume of 50 μL with 3 μL of the cDNA samples.
The reaction mixture contained 1× PCR buffer, 2 μM
dNTP, 3 nM of each primer and 1.25 units of Hot Start
Polymerase (Qiagen, Hilden, Germany). The PCR started
with a 95 °C step (15 min), followed by a denaturation
step at 94 °C for 30 s, 1 min of annealing at 55 °C and a
1 min extension at 72 °C. A final extension of 72 °C for
10 min was also carried out.
PCR products were submitted to electrophoresis in a
1.5% agarose gel, and the selected amplicons were purified
by Qiagen PCR clean-up kit, digested with XhoI/Acc561 re-
striction enzymes and cloned into the previously digested
expression vector pN3. Chemically TOP10 competent cells
(Invitrogen, Paisley, UK) were transformed and grown over-
night in LB agar plates supplemented with kanamycin
(50 ng/mL). Colonies were screened by PCR with specific
primers for the vector sequences, run in 1.5% agarose gel
and positive clones were selected and sequenced (Secugen,
Madrid, Spain).
Plasmids containing the correct IL-4, IL-13 or IL-10
sequence were employed for transfection of cultured
HEK 293-T cells using the Amaxa Nucleofector II device
and following the manufacturer’s protocol from Cell Line
Nucleofector Kit V (LONZA, Köln, Germany). After 72 h,
cell supernatants were collected, clarified by centrifuga-
tion and frozen at −80 °C. HEK 293-T cells were also
Table 1 Primers used for amplification and cloning of the cytokines and the Caev-Cork env gene used in entry assays.
Molecule Primer Probe Amplicon length
Forward Reverse
IL-4 AATTCTCGAGACCATGGGTCTCACCTCCCAGC AATTTGGTACCTCAACACTTTGAGTATTTCTCC 472 nt
IL-13 AATTCTCGAGACCATGGCGCTCTTCTTGAC ATTTGGTACCTCAGTTGTAACTTCCATTGCG 556 nt
IL-10 AATTCTCGAGACCATGCCCAGCAGCTCAG ATTTGGTACCTTACATCTTCGTTGTCATGTA 419 nt
CAEV-Cork env ATATAGATCTCCACCATG ATTTGCGGCCGCTATTAGTCCTCTTTAG 2834 nt
TNF-α qPCR GGTGCCTCAGCCTCTTCTC GAACCAGAGGCCTGTTGAAG 6-FAM-TGGTTGCAGGAGCCACCACG-TAMRA 134 nt
CD80 qPCR CTGTGATTACAACACGACCACTGA ATGGTGCGGTTCTCGTATTCA 6-FAM-AACTGGCAAGCCTTCGGATCTACTGGC-TAMRA 128 nt [30]
A3Z1 qPCR TCCGTTCTTGGAATCTGGAC GTATAGATGCGGGAGGCAAA 151 nt
MR qPCR TGGCAAATCCAGTTGTTAAGATGTT AGAATGTTGAATACTGTGGCGAGTT 91 nt [31]
DC-SIGN qPCR GGTTCCGGAGTCTGACTGAAGTT GGTCAGGCGCTGTAGGATCTC 73 nt
IL-10 qPCR CGGCGCTGTCATCGTTTT TCTTGGAGCATATTGAAGACTCTCTTC 6-FAM-CCTGCTCCACCGCCTTGCTCTTG-TAMRA 82 nt
Sequences are listed 5′to 3′; restriction enzyme recognition sites are underlined; Kozak sequences are in bold. A3Z1, MR and DC-SIGN were amplified using SybrGreen Master Mix (Takara).
Primers and probes (when corresponding) for relative expression quantification using real time PCR (qPCR) are also indicated.
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natant was used as a non-stimulated control.Quantification of cytokines for use as stimulators in
macrophage polarization
IFN-γ and IL-4 cytokine concentrations and biological ac-
tivities in HEK 293-T culture supernatants was measured
with the Ovine IFN-γ ELISA kit (Mabtech, Nacka Strand,
Sweden) and the Bovine IL-4 screening set (Thermo Scien-
tific, Rockford, USA), respectively, according to the manu-
facturers’ protocols. The concentration obtained was similar
in both cases, ranging from 600 to 2600 ng and was adjusted
to 50 ng/mL for use in MDM stimulations (see below).
In the absence of commercially available quantification
kits for small ruminant IL-10 and IL-13, the concentration
range of these cytokines in the HEK 293-T culture system
was assumed to be the same as for IFN-γ and IL-4. Never-
theless, biological activity was first verified by addition
of 5, 10 and 20-fold dilutions of the HEK 293-T culture
supernatants to MDM, followed by a 4 h incubation, cell
harvesting, RNA extraction and determination of marker
expression by real time RT-PCR (see below).Macrophage polarization
LPS and cytokines (IFN-γ, IL-4, IL-13 and IL-10) were
added to macrophages on day 3 of culture, at a final con-
centration of 50 ng/mL. Supernatants from HEK 293-T cul-
tures transfected with empty pN3 plasmid were used as the
negative control. Fresh medium supplemented with cyto-
kines was partially replaced after 3–4 days of culture. On
day 6, stimulated MDM were either collected for RNA
extraction and marker molecule expression analysis (at least
six independent wells for each treatment), or infected for
RT activity measurements or used in entry assay experi-
ments, as indicated below.Marker expression analysis by real time RT-PCR
RNA was extracted from cytokine treated and pN3-treated
MDM and real time RT-PCR were carried out using spe-
cific primers and probes according to the differentiation
pathway, TNF-α, CD80 and APOBEC3Z1 (A3Z1) for M1
phenotype and Mannose Receptor (MR), DC-SIGN and IL-
10 for M2 phenotype (Table 1). TNF-α, CD80 and IL-10
real time PCR procedures were performed using specific
probes and conditions described previously for CD80 [30]
A3Z1, MR and DC-SIGN expression was assessed with
specific primers and SybrGreen Master Mix (Takara, Otsu,
Japan) following conditions described previously [31].
β-actin expression was measured as a housekeeping gene,
thus β-actin Ct values were subtracted from the markers’
Ct values for each sample, in order to obtain the 2-ΔCt
values used for comparisons.Viral infections and RT activity determination
Six-day stimulated MDM were infected at 0.1 TCID50/cell
with one of the six SRLV strains under study, being one of
genotype A (Ev1), three of genotype B (CAEV-Co, CAEV-
To and 496) and two of the recently described genotype E
of SRLV (Roccaverano and Seui). Following 2-h incubation,
the cells were washed three times with PBS and fresh
medium containing the stimulating cytokines was added.
Supernatants were collected at 7 days post inoculation
for Retrotranscriptase activity (RT activity) quantification,
performed with the HS-Lenti RTactivity kit (Cavidi, Uppsala,
Sweden) according to the manufacturer’s instructions.
Viral pseudotype constructions and entry assay
Plasmids containing the envelope gene (env) of Roccaverano,
Seui [32] and Ev1 strains [33] were used. In addition,
CAEV-Co env was cloned into the pCMV plasmid [34]
using the same strategy and with the primer pairs
shown in Table 1. Positive clones were screened by restric-
tion enzyme digestion, sequencing and by assessing the
formation of syncitya in cultured skin fibroblasts. pMDG
plasmid encoding for vesicular stomatitis virus env
glycoprotein (VSV-G) was used as a positive control
(kindly provided by Prof. Greg J. Towers, University of
London, UK).
For entry assays, pseudotyped virions were produced
by co-transfection of HEK 293-T cells with two types of
plasmids as described [32]. Briefly, pCAEV-AP (enco-
ding alkaline phosphatase), kindly provided by Dr
Isidro Hötzel, [35]; and one of the env-containing plas-
mid constructs described above. HEK 293-T cell culture
supernatants containing the pseudotyped viruses were
collected after 48 h, clarified and used in 10-fold dilu-
tions to infect MDM, CHO and CHO-MR cells. After
48 h, the cells were stained using the alkaline phos-
phate substrate BCIP/NBT (Thermo Scientific) [36]
and the results were expressed as focus-forming unit
per mL (FFU/mL).
Mannan treatment
Stimulated and pN3-stimulated MDM, CHO and
CHO-MR cells were treated with 1 mg/mL of mannan
(Sigma-Aldrich), for 30 min at 37 °C and 5% CO2, and
infected with 10-fold dilutions of the pseudotyped vi-
ruses plus mannan following the entry assay procedure
described above. Cells non-treated with mannan were
included as controls.
Virus-induced polarization
MDM were allowed to differentiate in complete medium
without cytokine stimulation and then infected with 0.1
TCID50/mL of the six strains mentioned above (EV1,
CAEV-Co, CAEV-To, 496, Roccaverano and Seui). On day
7 of infection, the cells were harvested and RNA were
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Figure 1 Biological activity. Supernatants containing caprine IFN-γ (a), IL-4 (b), IL-13 (c) and IL-10 (d) produced in HEK293-T cells, as described
in Material and Methods were applied to MDM in serial dilutions (1/5, 1/10 and 1/20). Biological activity was evaluated as the relative expression
of TNF-α, MR and IL-10 evaluated by real time RT-PCR. Values are expressed as 2-ΔCt × 100 normalized to β-actin.
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http://www.veterinaryresearch.org/content/44/1/83extracted and retrotranscribed to cDNA. Real time PCR for
the detection of TNF-α, CD80, A3Z1, MR, DC-SIGN and
IL-10, were carried out as described above.
Macrophage versatility
MDM were obtained and allowed to differentiate into
M1 or M2 profiles with IFN-γ and IL-4 respectively
through two cycles of stimulation (3 days each). After
the second, MDM were washed and stimulated for 3
additional days with a cytokine of the opposite pheno-
type (M1 vs. M2), then RNA was obtained and cDNAwere subjected to specific amplification of differentiation
pathway markers.
Statistical analysis
The effects of different stimulators on marker expression
were tested evaluating correlation between 2-ΔCt and stimu-
lator concentration with the Spearman’s rank correlation
test. In order to evaluate the possible differences in expres-
sion among cells treated with different stimuli or non-
treated (i.e. control pN3 group), data were analysed using
Kruskal Wallis test. If a significant difference was recorded,
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Figure 2 Relative marker expression in stimulated MDM. MDM were cultured in the presence of the particular cytokine or control (pN3).
Relative expression of TNF-α (a), CD80 (b), A3Z1 (c), MR (d), DC-SIGN (e) and IL-10 (f) was measured by quantitative RT-PCR. The values are
expressed as 2-ΔCt × 100 median value (± interquartile range) of at least 3 independent experiments normalized to β-actin.
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http://www.veterinaryresearch.org/content/44/1/83a planned comparison between each treated cell group and
the control was performed using 2-tailed Wilcoxon rank-
sum test or Mann-Whitney’s test. Correlations and diffe-
rences were considered significant if associated p < 0.05.Results
Cytokine biological activity
Supernatants of HEK-293-T cells transfected with IL-13 or
IL-10 expression plasmids were found to affect MDM M1/
M2 marker expression (quantified by real-time RT-PCR).
Variation of M1/M2 markers was dose dependent (Figure 1).
IL-13 favored MR expression since higher dilutions showed
lower MR expression levels (Spearman Rho = 0.956, p <
0.005); similarly, TNF-α expression slightly increased with
higher dilutions of IL-13 (Spearman Rho p < 0.005), but
resulted in negligible variations. Even if the relationship is
not linear, IL-10 showed as did IL-13 a positive relation with
MR since the more cytokine is present the higher level of
MR expression is observed.
Therefore these cytokines, in addition to those whose
activity had been assessed by commercial kits (IFN-γ
and IL-4), were considered biologically active and suit-
able for further MDM stimulation studies.Characterization and plasticity of polarized macrophages
Phenotypic differences regarding cell morphology (shape
and size) were clearly observed between differentially stimu-
lated MDM after 3 days of cytokine stimulation. Specifically,
IFN-γ and LPS-treated (Th1 cytokines) cells were small and
round, whereas IL-4 treated MDM showed a dendritic-like
shape with large pseudopodia. Finally, in macrophages
exposed to IL-13, IL-10 and pN3 there appeared to be a
mixture of morphological phenotypes.
Phenotypic characterization was further evaluated after
two rounds (3 days each) of exposure to LPS, IFN-γ, IL-4,
IL-13 and IL-10, by assessing the expression of TNF-α,
CD80 and A3Z1 (M1 phenotype) and MR, DC-SIGN and
IL-10 (M2 phenotype) markers. Relative marker expression,
measured by real time RT-PCR (Figure 2) indicated that, as
described in other species, TNF-α expression increased in
IFN-γ stimulated MDM from caprine and ovine origin and
therefore this molecule could be a good marker for M1
polarization. In contrast, MR expression increased in IL-4
stimulated MDM and thus could be considered as a good
marker for M2 polarization.
Additional molecules evaluated in this study were identi-
fied as new markers for M1 or M2 macrophage popula-
tions. A3Z1 and CD80 were induced in IFN-γ stimulated
MDM, identifying M1 macrophages. Conversely, DC-SIGN
was highly expressed in IL-4 and IL-13 stimulated macro-
phages, identifying M2 macrophages (Figure 2).
IL-10 expression values did not seem to distinguish be-
tween different populations (p > 0.05 in all comparisons),although expression was mainly observed in IL-4, IL-10
and LPS stimulated macrophages.
Apart from these clear patterns of M1 vs. M2 polarization,
“single-effect” patterns associated to caprine or ovine species
were also identified. Specifically, LPS stimulation resulted in
highly increased levels of MR in goats and IL-10 in sheep
and not in increased M1 cytokines, whereas IL-13 induced
high levels of MR and DC-SIGN in both species. CD80 was
a good marker for M1 macrophages in the caprine species
whereas IL-4 stimulation led to expression of IL-10 only in
sheep.
pN3 induced the lowest levels of stimulation in ovine and
caprine macrophages. As in other animal models, pN3 (con-
trol) exposure resulted in increased levels of M2 marker
expression.
In order to explore whether M1 and M2 were irreversibly
differentiated cells, ovine macrophages were polarized into
M1 and M2 patterns by stimulation with IFN-γ and IL-4
respectively, and then stimulated with a cytokine of the op-
posite pattern (IL-4 and IFN-γ, respectively). When M1
(IFN-γ stimulated) macrophages expressing high levels of
TNF-α and A3Z1 markers were stimulated with IL-4, ex-
pression of these markers was significantly reduced (paired
Wilcoxon Rank Sum test p < 0.05 in both cases) while MR
and DC-SIGN expression was increased (p < 0.05 in both
cases, Figure 3). Similarly, when M2 (IL-4 stimulated) mac-
rophages were stimulated with IFN-γ, their profile changed
drastically towards phenotype M1 with increased expres-
sion of TNFα and A3Z1 (p < 0.05 in both cases) and signifi-
cant reduction of MR expression (p < 0.05). DC-SIGN only
showed a trend to lower expression (p = 0.1). These results
indicate that the polarization profile of small ruminant
MDM is plastic and M1 and M2 patterns defined here can
be reverted from one to the other according to cytokine
availability.
Susceptibility of MDM stimulated with cytokines to virus
infection
Firstly, the MDM-SRLV combinations permissive to SRLV
infection were chosen for infection after cytokine exposure.
Combinations were designed including ovine macrophages
and viral strains originally isolated from sheep, Ev1 (geno-
type A) or 496 (genotype B), and caprine macrophages and
viral strains originally obtained from goats (CAEV-Co,
CAEV-To, genotype B) or Roccaverano and Seui (genotype
E). The corresponding MDM were submitted to two con-
secutive 3-day rounds of stimulation with cytokines, and
then infected with different SRLV strains for 7 days to fi-
nally determine RT activity (Figure 4). The results indicate
that M2 stimulated MDM when exposed to SRLV clearly
favored viral replication. In contrast, M1 IFN-γ stimulated
cells showed a reduced RT activity upon SRLV infection
compared to cells exposed to pN3 or IL-4 (Wilcoxon Rank
Sum test p < 0.05; Figure 4). pN3 stimulated cells showed
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Figure 3 Macrophage plasticity. MDM were stimulated for a total of 9 days, 6 days with IFN-γ, IL-4 or pN3 (non-stimulated control) followed by
a 3-day stimulation with the opposite cytokine as indicated with arrows. Relative expression of the markers TNF-α (a), CD80 (b), A3Z1 (c), MR (d),
DC-SIGN (e), and IL-10 (f) was quantified by real time RT-PCR after 6 days of total stimulation. The values are expressed as the median (± interquartile
range) 2-ΔCt × 100 value related to β-actin, and represent at least 3 independent experiments. *p < 0.05 (paired Wilcoxon Rank Sum test).
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http://www.veterinaryresearch.org/content/44/1/83high levels of viral replication compatible with an M2
phenotype as shown in Figure 3. Thus, the ability to support
SRLV replication (pattern of RT activity) differed according
to the stimulatory cytokine, with IFN-γ (M1 phenotype)
efficiently inhibiting infection independently of the strain
or the ruminant species from which MDM were isolated.
SRLV infection promotes the M2 differentiation pathway
Knowing that different cytokines trigger the establishment
of different polarization patterns in small ruminant macro-
phages, we explored the hypothesis that SRLV would also
induce a particular polarization pattern. For this and in the
absence of cytokine stimulation, MDM were infected with
different SRLV strains and differentiation markers quanti-
fied on day 7 of infection. All the SRLV strains used in this
study induced upregulation of M2 phenotype markers, with
increased MR and DC-SIGN expression values comparedto those of pN3 treated (Figure 5). M2 pattern of differenti-
ation was more evident when comparing M1 vs M2
markers since pN3 stimulation alone induced an M2
polarization (Figure 2). While M1 markers were induced to
a maximum of 2-fold compared with the housekeeping
gene, M2 marker induction was up to 75-times higher than
that of β-actin (Figure 5).
In contrast, TNFα, CD80 and A3Z1 and IL-10 expres-
sion did not increase upon infection with most of the
strains. Remarkably, infection with Seui strain induced
higher TNFα, CD80 and IL-10 expression than pN3
treated cells (Figure 5).
Env-mediated entry studies with pseudotyped viruses
and MR involvement
Knowing, on the one hand, the capacity of SRLV to infect
MDM and trigger the production of an M2 phenotype
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Figure 4 SRLV replication in polarized macrophages. MDM were
exposed for 6 days to the cytokines IFN-γ, IL-4, or pN3 (non-stimulated
control), and subsequently infected with different SRLV strains: EV1
(empty bars), 496 (full bars), CAEV-Cork (grey bars) CAEV-To (light grey
bars), Roccaverano (horizontal-lined bars) and Seui (vertical-lined bars).
RT activity was measured (A450nm) in clarified supernatants at 7 days
post infection. The values are the median (± interquartile range) of at
least 3 independent experiments. * p< 0.05 (paired Wilcoxon Rank
Sum test).
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http://www.veterinaryresearch.org/content/44/1/83(above) and, on the other hand, the possible role of MR in
SRLV entry and infection [31] and the increased production
of MR upon IL-4 stimulation, we first studied env-
mediated viral entry using for infection, pseudoviruses
expressing the envelope protein of known SRLV strains
(Ev1, CAEV-Co, Roccaverano, Seui) or VSV protein G
(Figure 6a). The results indicate that viral entry into
MDM was not affected by the particular macrophage
phenotype (M1 or M2) since IFN-γ and IL-4 stimulated
macrophages showed similar numbers of focus forming
units with the different pseudotypes.
Viral entry was significantly inhibited by mannan treat-
ment when using Roccaverano pseudotyped particles overall
in IL-4 stimulated MDM, and the inhibitory effect was
non-significant for Ev1, CAEV-Co, Seui or VSV-G
pseudotyped virions. The highest entry values were reached
with pantropic VSV-G pseudovirions, as expected (Figure 6a).
Next, we determined if the mannan blocking effects of
env-mediated entry and subsequent infection could be
attributed to the involvement of the MR receptor at viral
entry, also using for this the pseudoviruses described
above. For this we used CHO-MR cells stably expressing
MR [24], but not other SRLV receptors, and assessed the
effect of mannan treatment (Figure 6b). CHO-MR cells
challenged with EV1, CAEV-Co, Roccaverano, Seui or
VSV-G pseudotyped viruses showed a heterogeneous
pattern of viral entry and suggest that mannan exposure
would inhibit infections by Ev1, Roccaverano and Seuipseudotyped virions but did not hamper CAEV-Co or
VSV-G entry (Figure 6b).
Discussion
In SRLV infections, immune responses constitute a double-
edge sword, since on one side they are essential against in-
fections [37] and on the other side they lead to follicular
hyperplasia and mononuclear cell infiltration, the main
causes of tissue damage in SRLV-related lesions [11,38].
Macrophages, the main target cells for SRLV infection, play
a pivotal role in the process, disseminating the virus and
providing antigen, costimulatory signals and cytokines, in-
ducers or regulators of immune responses. In addition,
macrophages suffer alterations upon lentiviral infection, but
subsets of macrophages have not been identified yet in
small ruminant species. Our results, strongly suggest that
M1 and M2, main patterns of differentiation, are well con-
served among species - including small ruminants - being
induced by IFN-γ and IL-4, respectively. In small rumi-
nants, stimulation with M1-like stimulus (IFN-γ) clearly in-
duced an increased expression of not only TNF-α, as in
humans and mice [39] but also APOBEC3 (A3Z1) and the
costimulatory molecule CD80, together with a decreased
expression of MR and DC-SIGN. Conversely, stimulation
with M2 stimulus (IL-4, IL-13, IL-10) conferred an induc-
tion of not only MR but also DC-SIGN and IL-10. Interes-
tingly, LPS and negative controls (pN3) induced an
intermediate (M1-to-M2) pattern and a clear M2 pattern,
respectively. LPS has been associated with an M2b profile
[19], with high levels of proinflammatory cytokines together
with high IL-10 [40,41] as shown by our studies.
SRLV viral infection induced M2 polarization of mac-
rophages, which also exhibited high MR and DC-SIGN
expression as observed upon IL-4 stimulation. If this
SRLV-mediated M2 induction occurs in vivo in alveolar
macrophages of infected animals, infection would be en-
hanced, as these cells would show a M2 phenotype with
a high expression of pattern-recognition receptors such
as MR and scavenger receptors [42]. This pattern would
favor viral spread as observed [43] and also in this study
using M2 polarized macrophages. Ovine alveolar macro-
phages expressing scavenger receptor CD163, a hallmark
of M2 differentiation, were found to be highly related to
the presence of SRLV capsid protein in persistently
infected sheep [44], in agreement with our results. How-
ever, during early infection in vivo, new M1 cells may in-
filtrate into the tissue and initially control the incoming
virus. After encountering the virus (Figure 5) and also
for physiological reasons (M1 cells last a few days; [45]),
these M1 would eventually switch to M2 macrophages
[46] allowing virus replication as well as infection spread
since M2 cells can live from several weeks to years [47].
M1 cells are non-motile since inflammation is better tol-
erated in a restricted site, but M2 cells instead are motile
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Figure 5 Virus-induced polarization of MDM. MDM were allowed to differentiate in the absence of cytokine and then infected with different
SRLV strains (EV1, 496, CAEV-Cork, CAEV-To, Roccaverano and Seui) at a MOI of 0.1. Six day post-infection relative expression of the markers TNF-α
(a), CD80 (b), A3Z1 (c), MR (d), DC-SIGN (e), and IL-10 (f) was measured by quantitative RT-PCR. The values are expressed as 2-ΔCt × 100, related
to β-actin, and represent the median (± interquartile range) of at least 3 independent experiments.
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across a 3D matrix [48] favoring infection spread to
other target organs. M2 cells are tolerogenic and surely
are the main macrophages in SRLV infection sinceanimals that reach the clinical stage present high levels
of IgG1, IL-4 and low levels of B7 molecule transcripts
that would impair antigenic presentation leading to
anergic responses and T cell exhaustion. However, care
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Figure 6 Entry assay with pseudotyped viral particles. IFN-γ, IL-4 and pN3 (control) stimulated MDM (a) and CHO-MR (b) were either treated
or non-treated with mannan (1 mg/mL) before infection with pseudoviral particles bearing the envelope glycoproteins of the strains EV1 (empty
boxes), CAEV-Cork (grey boxes), Roccaverano (horizontal-lined boxes), Seui (vertical-lined boxes) or the control VSV-G (full boxes). Foci of
transduced cells were counted using alkaline phosphatase activity staining. Values are expressed as median focus-forming units per mL (FFC/mL)
of at least 3 independent experiments.
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is also plausible that M1 cells somehow impaired in
their ability to restrict SRLV, could be responsible for
both the tolerance and immunomediated lesions.
The Roccaverano SRLV strain showed an increased entry
level into M2 macrophages compared to M1 suggesting a
different receptor usage for genotype E1, whereby this geno-
type would enter the cell mainly via mannose recognizing
receptors such as MR, whereas other strains would use add-
itional receptors present in macrophages [31,32]. The levels
of env-related entry into CHO-MR cells found in this study
in the presence/absence of mannan may also suggest that
SRLV can enter M2 cells via MR.
M2, the most susceptible macrophages for SRLV infec-
tion, could allow viral proliferation and promote pathoge-
nesis in vivo by at least two different mechanisms. One
pathway would involve cellular receptors that may allow or
enhance viral entry, and the other related to poor expres-
sion of B7 (CD80/86) costimulatory molecules, also ob-
served here in M2 profiles, which would lead to the lack of
T cell responses in vivo [30]. Arguing also in favour of these
mechanisms, are studies showing that IFN-γ (leading to the
M1 phenotype) selectively down regulates activity of MR
[49,50] and M1 chemokines amplify the DTH response,
which is reduced in SRLV affected animals [51].
Interestingly, infection block (decreased RT-activity) in
M1 compared to M2 MDM did not occur at the entry
step, since the degree of entry was similar in M1 and
M2 cells. Rather, blockage occurred at post-entry stepssince preliminary qPCR data suggest that integration,
evaluated as proviral load, was lower in IFN-γ than IL-4
stimulated cells (data not shown). Post-integration restric-
tion may include the involvement of TRIM5 and APOBEC,
as described in human HIV-1 infections [22]. M1 and M2
human macrophages showed restriction against HIV-1 in-
fection by inducing factors like APOBEC3G or reducing
the expression of certain receptors (CD4) respectively [22].
In this study, M1 differentiation may have restricted SRLV
replication through A3Z1 induction, according to the A3Z1
mRNA levels observed. Conversely, M2 favoured virus rep-
lication likely due to differential receptor usage of SRLV
compared with HIV-1.
Macrophages respond to stimuli temporarily reverting
their differentiation pattern, depending on the cytokine
present [52,53]. Thus polarization is a continuous reversible
M1/M2 differentiation process, as confirmed in ovine mac-
rophages, reflecting that profiles are not static terminally-
differentiated states. This plasticity may have important con-
sequences in chronic lentiviral infections where SRLV repli-
cates at higher levels in M2 compared to M1 macrophages.
Different strategies can be proposed in order to block or at
least relieve M2 differentiation and therefore viral spread,
since macrophages do not necessarily suffer apoptosis or
emigration after inflammation [54,55]. These strategies have
been applied against tumour diseases, where an M2 pheno-
type of macrophages may predominate [56] and the cure
has involved a switch of the immune response to M1 by
pharmacological treatment [57].
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noviruses show a reduced antibacterial capacity [58] and
also SRLV infected macrophages showed a reduced phago-
cytic activity against bacteria indirectly facilitating secondary
infections [59] suggesting the induction of an M2 pheno-
type. Mycoplasma co-infection malp (macrophage activation
lipoprotein) may modify proteins presented on the plasmatic
membrane that could act as SRLV (co)-receptors and favour
infection [60]. Essentially, data regarding macrophage diffe-
rentiation and characterization of the respective profiles
share several features with the well depicted picture in
humans and mice strongly suggesting a widely conserved
maturation pathway, further reinforcing the M1/M2 model
and validating their use.
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